JNT-517

DB19305InvestigationalSmall molecule

JNT-517: Overview.

Mechanism: Pharmacologically active on Sodium-dependent neutral amino acid transporter B(0)AT1
Curator reviewed
Formula / weight: C₁₈H₂₂F₄N₄O₃ · 418.393 g/mol (avg)
Also known as: (R)-3-(1-cyclopropyl-3-(2-fluoro-4-(trifluoromethoxy)benzyl)ureido)piperidine-1-carboxamide · 1-Piperidinecarboxamide, 3-[cyclopropyl[[[[2-fluoro-4-(trifluoromethoxy)phenyl]methyl]amino]carbonyl]amino]-, (3R)-
Code names: JNT-517

Resolves to

Compound

Structure

InChIKeyFNRHWODWSBDOOY-CYBMUJFWSA-NSMILES[H][C@]1(CCCN(C1)C(O)=N)N(C1CC1)C(\O)=N\CC1=C(F)C=C(OC(F)(F)F)C=C1

Targets

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with JNT-517, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.